Kopran zooms as its arm gets process patent for API product

13 Dec 2021 Evaluate

Kopran is currently trading at Rs. 277.75, up by 6.90 points or 2.55% from its previous closing of Rs. 270.85 on the BSE.

The scrip opened at Rs. 284.35 and has touched a high and low of Rs. 284.35 and Rs. 273.35 respectively. So far 52778 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 303.55 on 06-Dec-2021 and a 52 week low of Rs. 99.80 on 17-Mar-2021.

Last one week high and low of the scrip stood at Rs. 303.55 and Rs. 263.40 respectively. The current market cap of the company is Rs. 1200.64 crore.

The promoters holding in the company stood at 43.78%, while Institutions and Non-Institutions held 0.73% and 55.50% respectively.

Kopran’s arm has received process patent for API product. The Indian Patent office has granted Process Patent for 20 years to Kopran Research Laboratories, Wholly owned Subsidiary of the Company for the Active Pharmaceutical Ingredient (API) product NITROXOLINE, for the invention titled ‘improved, cost effective process for producing NITROXOLINE’.

Kopran is engaged primarily in pharmaceuticals business.

Kopran Share Price

135.60 -4.10 (-2.93%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×